LUMOS PHARMA, INC. Insider Trading for January 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LUMOS PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LUMOS PHARMA, INC. for January 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 27 2015 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Option Exercise | M | 7.00 | 2,500 | 17,500 | 3,056 | |
| Jan 27 2015 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Sell | S | 40.00 | 2,500 | 100,000 | 41,667 | 44.2 K to 41.7 K (-5.66 %) |
| Jan 27 2015 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Buy | M | 7.00 | 2,500 | 17,500 | 44,167 | 41.7 K to 44.2 K (+6.00 %) |
| Jan 08 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 37.77 | 15,000 | 566,550 | 591,118 | 606.1 K to 591.1 K (-2.47 %) |
| Jan 08 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 42.25 | 200 | 8,450 | 606,118 | 606.3 K to 606.1 K (-0.03 %) |
| Jan 08 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 38.51 | 4,800 | 184,848 | 606,318 | 611.1 K to 606.3 K (-0.79 %) |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Option Exercise | A | 43.65 | 24,800 | 1,082,520 | 24,800 | |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Grant | A | 0.00 | 7,800 | 0 | 41,667 | 33.9 K to 41.7 K (+23.03 %) |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Ramsey William J. | Quality Assurance O ... | Payment of Exercise | F | 43.65 | 658 | 28,722 | 33,867 | 34.5 K to 33.9 K (-1.91 %) |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Option Exercise | A | 43.65 | 6,500 | 283,725 | 6,500 | |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Grant | A | 0.00 | 2,000 | 0 | 47,789 | 45.8 K to 47.8 K (+4.37 %) |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Option Exercise | M | 11.79 | 20,000 | 235,800 | 129,000 | |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Option Exercise | A | 43.65 | 23,400 | 1,021,410 | 23,400 | |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Sell | S | 40.98 | 10,000 | 409,800 | 13,686 | 23.7 K to 13.7 K (-42.22 %) |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Sell | S | 39.68 | 10,000 | 396,800 | 23,686 | 33.7 K to 23.7 K (-29.69 %) |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Buy | M | 11.79 | 20,000 | 235,800 | 33,686 | 13.7 K to 33.7 K (+146.13 %) |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Grant | A | 0.00 | 7,400 | 0 | 13,686 | 6.3 K to 13.7 K (+117.72 %) |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Payment of Exercise | F | 43.65 | 540 | 23,571 | 6,286 | 6.8 K to 6.3 K (-7.91 %) |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Option Exercise | A | 43.65 | 143,000 | 6,241,950 | 143,000 | |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Grant | A | 0.00 | 45,000 | 0 | 611,118 | 566.1 K to 611.1 K (+7.95 %) |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Payment of Exercise | F | 43.65 | 1,700 | 74,205 | 566,118 | 567.8 K to 566.1 K (-0.30 %) |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Option Exercise | A | 43.65 | 81,000 | 3,535,650 | 81,000 | |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Grant | A | 0.00 | 25,000 | 0 | 57,983 | 33 K to 58 K (+75.80 %) |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Payment of Exercise | F | 43.65 | 1,161 | 50,678 | 32,983 | 34.1 K to 33 K (-3.40 %) |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Option Exercise | A | 43.65 | 16,300 | 711,495 | 16,300 | |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Grant | A | 0.00 | 5,100 | 0 | 10,249 | 5.1 K to 10.2 K (+99.05 %) |
| Jan 06 2015 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Payment of Exercise | F | 43.65 | 551 | 24,051 | 5,149 | 5.7 K to 5.1 K (-9.67 %) |